All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).
Poster Presentation Dates
All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.
Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.
|607||Oral Presentation||TJ210 (MOR210), A Differentiated Anti-C5aR Antibody for Anti-Cancer Therapy||Jane Meng, PhD; Jane Meng, PhD; Zhengyi Wang, PhD; Wei Cao; Chan Chen; Joan Huaqiong Shen, MD, PhD; Christian Augsberger; Julia Neugebauer; Stefan Haertle;||Immune-stimulants and immune modulators||Antibody; MDSC; Monocyte/Macrophage; Myeloid cells; Solid tumors; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment|